In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani

Biomedicine and Pharmacotherapy

Volumn 61, Issue 2-3, 2007, Pages 186-188

  Nakayama, H ^a   Desrivot, J ^b   Bories, C ^b   Franck, X ^b   Figadere B ^b   Hocquemiller, R ^b   Fournet, A ^c   Loiseau, P M ^b  

^a Instituto de Investigaciones en Ciencias de la Salud Universidad Nacional de Asuncion   (Paraguay)

^b UNIVERSITÉ PARIS SUD   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Leishmania donovani; Nitrilquinoline; Oral treatment

Indexed keywords

2 NITRILQUINOLINE; ANTILEISHMANIAL AGENT; MILTEFOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; LEISHMANIASIS; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 34147217221     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.02.001     Document Type: Article

References (9)

1. Croft S.L., Sundar S., and Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev 19 (2006) 111-126
2. Davis A.J., and Kedzierski L. Recent advances in antileishmanial drug development. Curr Opin Investig Drugs 6 (2005) 163-169
3. Fakhfakh M.A., Fournet A., Prina E., Mouscadet J.F., Franck X., Hocquemiller R., et al. Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11 (2003) 5013-5023
4. Franck X., Fournet A., Prina E., Mahieux R., Hocquemiller R., and Figadère B. Biological evaluation of substituted quinolines. Bioorg Med Chem Lett 14 (2004) 3635-3638
5. Nakayama H., Loiseau P.M., Bories C., Torres de Ortiz S., Schinini A., Rojas de Arias A., et al. Oral efficacy of 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 49 (2005) 4950-4956
6. Martinez-Grueiro M.M., Gimenez-Pardo C., Gomez-Barrio A., Fournet A., Franck X., Hocquemiller R., et al. Nematocidal and trichomonacidal activity of 2-substituted quinolines. Farmaco 60 (2005) 219-224
7. Okpekon T., Yolou S., Gleye C., Roblot F., Loiseau P.M., Bories C., et al. Antiparasitic activities of medicinal plants used in Ivory Coast. J Ethnopharmacol 90 (2004) 91-97
8. Stauber L.A., Franchino E.M., and Grun J. An eight-day method for screening compounds against Leishmania donovani in the golden hamster. J Protozool 5 (1958) 269-273
9. Belliard A.M., Baune B., Fakhfakh M., Hocquemiller R., and Farinotti R. Determination of the human cytochrome P 450 involved in the metabolism of 2-n-propylquinoline. Xenobiotica 33 (2003) 341-355